Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
Background Angiotensin-converting-enzyme inhibitors improve the outcome among patients
with left ventricular dysfunction, whether or not they have heart failure. We assessed the …
with left ventricular dysfunction, whether or not they have heart failure. We assessed the …
Beta blockade during and after myocardial infarction: an overview of the randomized trials
S Yusuf, R Peto, J Lewis, R Collins, P Sleight - Progress in cardiovascular …, 1985 - Elsevier
An imbalance in oxygen supply and demand......................................................................... 337
Experimental evidence for possible mechanisms of benefit from beta blockade in acute MI …
Experimental evidence for possible mechanisms of benefit from beta blockade in acute MI …
[HTML][HTML] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a …
…, M Hill, C Knott, S Parish, D Simpson, P Sleight… - The Lancet, 2011 - thelancet.com
Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial
infarction, ischaemic stroke, and the need for coronary revascularisation in people without …
infarction, ischaemic stroke, and the need for coronary revascularisation in people without …
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
R Garg, S Yusuf, WD Bussmann, P Sleight, A Uprichard… - Jama, 1995 - jamanetwork.com
Objective. —To evaluate the effect of angiotensin-converting enzyme (ACE) inhibitors on
mortality and morbidity in patients with symptomatic congestive heart failure. Data Sources and …
mortality and morbidity in patients with symptomatic congestive heart failure. Data Sources and …
[HTML][HTML] Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an …
…, T Saruta, J Schrader, R Schrier, P Sever, P Sleight… - The Lancet, 2021 - thelancet.com
Background The effects of pharmacological blood pressure lowering at normal or high-normal
blood pressure ranges in people with or without pre-existing cardiovascular disease …
blood pressure ranges in people with or without pre-existing cardiovascular disease …
Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity
HS Smyth, P Sleight, GW PICKERING - Circulation research, 1969 - Am Heart Assoc
The control of arterial pressure during sleep was studied in 13 untreated, unsedated subjects
aged 20 to 46, including 7 with hypertension. Arterial pressure was measured directly. A …
aged 20 to 46, including 7 with hypertension. Arterial pressure was measured directly. A …
Effect of age and high blood pressure on barorefiex sensitivity in man
B Gribbin, TG Pickering, P Sleight, R Peto - Circulation research, 1971 - Am Heart Assoc
The purpose of this study was to relate baroreflex sensitivity to age and arterial pressure in
61 male and 20 female untreated subjects, aged 19-66 years, whose mean arterial pressures …
61 male and 20 female untreated subjects, aged 19-66 years, whose mean arterial pressures …
[HTML][HTML] 2013 ESH/ESC practice guidelines for the management of arterial hypertension: ESH-ESC the task force for the management of arterial hypertension of the …
…, LM Ruilope, RE Schmieder, PA Sirnes, P Sleight… - Blood …, 2014 - Taylor & Francis
The 2013 ESH/ESC guidelines continue to adhere to some fundamental principles that
inspired the 2003 and 2007 guidelines, namely (i) to base recommendations on properly …
inspired the 2003 and 2007 guidelines, namely (i) to base recommendations on properly …
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
…, J Pogue, JM Arnold, C Ross, A Arnold, P Sleight… - Jama, 2005 - europepmc.org
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a
randomized controlled trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
randomized controlled trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial
…, L Hansson, Y Lacourcière, J Muller, P Sleight… - Jama, 2003 - jamanetwork.com
ContextHypertensive patients are often given a calcium antagonist to reduce cardiovascular
disease risk, but the benefit compared with other drug classes is controversial.ObjectiveTo …
disease risk, but the benefit compared with other drug classes is controversial.ObjectiveTo …
